CymitQuimica logo

Cerdulatinib (PRT2070)

Ref. 3D-YXB30079

50mg
Discontinued
100mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

Cerdulatinib (PRT2070)
Biosynth

    Product Information

    Name:Cerdulatinib (PRT2070)
    Brand:Biosynth
    Description:Cerdulatinib (PRT2070) is an ester hydrochloride compound with antifibrotic properties. It has been shown to inhibit the growth and proliferation of fibroblasts, which play a key role in the development of fibrosis. Cerdulatinib works by targeting alpha-tocotrienol, nintedanib, sildenafil, and other nucleophilic compounds involved in fibrotic pathways. Additionally, it has been found to inhibit fatty acid synthesis and collagen production, further contributing to its anti-fibrotic effects. Research suggests that cerdulatinib may also modulate the activity of β-catenin, a protein involved in cell signaling pathways related to fibrosis. This compound shows promise as a potential therapeutic option for various fibrotic conditions.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:445.54 g/mol
    Formula:C20H27N7O3S
    Purity:Min. 95%

    Inquiry about discontinued product: Cerdulatinib (PRT2070)

    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.